Analysis of publicly available TCGA data revealed that high SEMA3A expression was associated with poorer survival in clear cell renal cell carcinoma (ccRCC) (Fig. 6a), while another Semaphorin, SEMA4A was not (Supplementary Fig. 6A). The gene discussed is SEMA4A; the disease is clear cell renal carcinoma.